Veeva Introduces New ePRO App for Faster Access to Patient Data

Veeva ePRO simplifies the collection and exchange of patient-reported results in digital clinical trials

PLEASANTON, Calif., October 18, 2022 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced the availability of Veeva ePRO, a key advancement in patient-centric digital trials. The app makes it easier for patients to complete assessments on a mobile device or web browser and enables real-time data access for sponsors and clinical research sites. As part of a connected platform for clinical trials, study teams can use ePRO to exchange high-quality data across the clinical ecosystem for improved transparency and collaboration.

According to research sites, the top challenges with patient retention include the time it takes to participate in a trial, repetitive information requests, and time spent entering data.[1] Veeva ePRO enhances the patient experience by providing a modern, easy-to-use app to supplement patient-reported outcomes (PRO).

The app also helps streamline trial activities for sponsors and research sites. Sponsors can configure studies using survey and instrument libraries and push ePRO and schedule definitions to research sites. Research sites can then easily assign activities, automatically receive updates, and track patient progress without the need for other systems or applications.

“Veeva ePRO is designed to meet the needs of patients, sites and sponsors, and is connected for end-to-end execution,” said Tim Davis, Vice President of Strategy, MyVeeva for Patients at Veeva. “We are committed to partnering with our customers to deliver modern digital applications that help the life sciences industry transition to patient-centric digital trials.”

Veeva ePRO is part of Veeva Vault Clinical Suite, the industry’s first cloud-based platform that unifies clinical data management and operations. Vault Clinical Suite includes Vault EDC, Veeva RTSM, Veeva ePRO, Veeva CDB, Vault eTMF, Vault CTMS, Veeva Site Connect, Vault Payments, Vault Study Start-up, and Vault Study Training. Learn more about Veeva ePRO at

Further information

Connect with Veeva on LinkedIn: Follow @veevasystems on Twitter:

About Veeva systems

Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a public benefit company, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit

Veeva forward-looking statements

This release contains forward-looking statements regarding Veeva’s products and services and the expected results or benefits of using our products and services, including some of our new solutions and applications that are still under development or not generally available. These statements are based on our current expectations. The actual results, availability and any future events relating to these products and services could differ materially from those provided in this press release and we have no obligation to update these statements. There are numerous risks that could adversely impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2022, which you can find here (a summary of risks that may impact our business can be found on pages 39 and 40), and in our filings with the SEC, which you can access at


Deivis Mercado
Veeva Systems
[email protected]

1 SCRS Research Report, Assessing the Impact of eClinical Technologies and Industry Initiatives on Sites, 2019

SOURCE Veeva Systems